
CAIROLI ROBERTO
Pubblicazioni
Duca, F., Manghisi, B., Palasciano, A., Mochi, A., Parma, M., Greco, R., et al. (2026). DNMT3A Co-Mutation and Real-World Clinical Outcomes With Gilteritinib in FLT3-Mutated Acute Myeloid Leukaemia Across Molecular Subgroups. EJHAEM, 7(4) [10.1002/jha2.70374]. Dettaglio
Ansuinelli, M., Peragine, N., De Propris, M., Puzzolo, M., Di Trani, M., Elia, L., et al. (2026). Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia. LEUKEMIA, 40(3), 577-586 [10.1038/s41375-025-02855-5]. Dettaglio
Tirloni, G., Chiavetta, V., Villemonteix, J., Jorge-Cordeiro, D., Grillo, G., Cairoli, R., et al. (2026). Association analysis between HLA evolutionary divergence and CMV serological status in a cohort of 526 adult subjects. TRANSPLANT IMMUNOLOGY, 98(October 2026) [10.1016/j.trim.2026.102446]. Dettaglio
Stefanucci, M., Leuzzi, L., Montavoci, L., Bernasconi, D., Cimaschi, L., Trojani, A., et al. (2026). The Germline SH2B3rs111340708 Splicing Variant Drives Intron Retention and Protein Instability by Impacting Clinical Outcomes in Core Binding Factor AML. HEMATOLOGICAL ONCOLOGY, 44(5) [10.1002/hon.70254]. Dettaglio
Petruzzelli, D., Vignetti, M., Trasarti, S., Sportoletti, P., Torre, S., Cairoli, R., et al. (2026). Erratum in: Exploring the administrative burden faced by hematologists: A comprehensive study in Italy, (Global and Regional Health Technology Assessment, (2024), 11(1), (161–168), (10.33393/grhta.2024.3042)) [Altro] [10.33393/grhta.2026.3725]. Dettaglio
Premi e responsabilità scientifiche
Incarichi di insegnamento o ricerca
- Docente a contratto - GENETICA EMATOLOGICA - Università degli Studi di MILANO, 1999 - 2013